Skip to main content

Advertisement

Log in

Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors

  • ORIGINAL ARTICLE
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Although the use of staging laparoscopy (SL) for detecting peritoneal metastasis (P) and determining peritoneal lavage cytology (CY) is widespread in advanced gastric cancer, an indication for SL based on preoperative clinicopathological factors is controversial.

Methods

From May 2006 to September 2015, 120 patients with advanced gastric cancer with primary tumors ≥5 cm and/or with bulky regional lymph nodes (bulky N) underwent SL for assessment of P/CY status. Clinicopathological factors were analyzed retrospectively to determine their influence on peritoneal spread (P1 and/or CY1). An additional analysis of 379 consecutive patients with clinically T2 or deeper gastric cancer in the same time period was carried out to confirm the SL results.

Results

Peritoneal spread was confirmed by SL in 54 cases (45%). The presence of type-4 tumors (n = 38, p < 0.0001) and diffuse-type tumors (n = 85, p = 0.04) correlated significantly with peritoneal spread. These two factors were also correlated significantly with increased peritoneal spread in a subgroup analysis among patients with tumors with bulky N (n = 44). The additional analysis of 379 patients showed results consistent with the SL results. The frequency of peritoneal spread was 78% among type-4 tumors, 47% among diffuse-type tumors ≥5 cm, and 38% among diffuse-type tumors with bulky N, whereas among intestinal-type tumors, it was 18% in tumors ≥5 cm and 13% among tumors with bulky N.

Conclusions

Among tumors ≥5 cm or with bulky N, type-4 tumors and diffuse-type tumors had a high potential for peritoneal spread and patients with such tumors were considered more suitable candidates for SL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221

    Article  CAS  PubMed  Google Scholar 

  2. Burbidge S, Mahady K, Naik K (2013) The role of CT and staging laparoscopy in the staging of gastric cancer. Clin Radiol 68:251–255

    Article  CAS  PubMed  Google Scholar 

  3. Burke EC, Karpeh MS, Conlon KC, Brennan MF (1997) Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 225:262–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Nakagawa S, Nashimoto A, Yabusaki H (2007) Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer 10:29–34

    Article  CAS  PubMed  Google Scholar 

  5. Tsuchida K, Yoshikawa T, Tsuburaya A, Cho H, Kobayashi O (2011) Indications for staging laparoscopy in clinical T4 M0 gastric cancer. World J Surg 35:2703–2709

    Article  PubMed  Google Scholar 

  6. Miki Y, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M (2015) Staging laparoscopy for patients with cM0, type 4, and large type 3 gastric cancer. World J Surg 39:2742–2747

    Article  PubMed  Google Scholar 

  7. Ajani JA, Bentrem DJ, Besh S et al (2013) Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 11:531–546

    CAS  Google Scholar 

  8. Karanicolas PJ, Elkin EB, Jacks LM et al (2011) Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg 213:644–651

    Article  PubMed  Google Scholar 

  9. D’Ugo D, Persiani R, Caracciolo F, Ronconi P, Coco C, Picciocchi A (1997) Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc 11:1159–1162

    Article  PubMed  Google Scholar 

  10. Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS (2006) Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg 191:134–138

    Article  PubMed  Google Scholar 

  11. Yano M, Tsujinaka T, Shiozaki H et al (2000) Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J Surg 24:1130–1135

    Article  CAS  PubMed  Google Scholar 

  12. Shimizu H, Imamura H, Ohta K et al (2010) Usefulness of staging laparoscopy for advanced gastric cancer. Surg Today 40:119–124

    Article  PubMed  Google Scholar 

  13. Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, Stomach Cancer Study Group of the Japan Clinical Oncology Group (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660

    Article  CAS  PubMed  Google Scholar 

  14. Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K (2000) Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol 75:165–171

    Article  CAS  PubMed  Google Scholar 

  15. Habermann CR, Weiss F, Riecken R et al (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465–471

    Article  PubMed  Google Scholar 

  16. Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y (2009) Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol 16:3227–3236

    Article  PubMed  Google Scholar 

  17. Satoh S, Okabe H, Teramukai S et al (2012) Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer 15:61–69

    Article  CAS  PubMed  Google Scholar 

  18. Okabe H, Tsunoda S, Hosogi H et al (2015) Circulating tumor cells as an independent predictor of survival in advanced gastric cancer. Ann Surg Oncol 22:3954–3961

    Article  CAS  PubMed  Google Scholar 

  19. UICC International Union Against Cancer (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York, pp. 73–77

    Google Scholar 

  20. Japanese classification of gastric carcinoma: 3rd English edition (2011) Japanese gastric cancer association. Gastric Cancer 14:101–112

    Article  Google Scholar 

  21. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    CAS  PubMed  Google Scholar 

  22. Iwasaki Y, Sasako M, Yamamoto S et al (2013) Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 107:741–745

    Article  CAS  PubMed  Google Scholar 

  23. Roviello F, Marrelli D, de Manzoni G et al (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1119

    Article  CAS  PubMed  Google Scholar 

  24. Yasuda K, Shiraishi N, Inomata M, Shiroshita H, Izumi K, Kitano S (2007) Prognostic significance of macroscopic serosal invasion in advanced gastric cancer. Hepato-Gastroenterology 54:2028–2031

    PubMed  Google Scholar 

  25. Okabe H, Hata H, Ueda S et al (2015) A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03. J Surg Oncol 113:36–41

    Article  PubMed  Google Scholar 

  26. Kodera Y, Ito S, Mochizuki Y et al (2009) A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol 35:1158–1163

    Article  CAS  PubMed  Google Scholar 

  27. De Andrade JP, Mezhir JJ (2014) The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J Surg Oncol 110:291–297

    Article  PubMed  Google Scholar 

  28. Seshadri RA, Glehen O (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 22:1114–1130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author’s contributions

Study conception and design: Hosogi H and Okabe H; acquisition of data: Hosogi H and Sumida H; analysis and interpretation of data: Tsunoda S, Hisamori S, Hida K, and Obama K; drafting of manuscript: Hosogi H; critical revision of manuscript: Shinohara H, Tsunoda S, Okabe H, and Sakai Y.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hisahiro Hosogi.

Ethics declarations

Funding

No funding was received for research or publication.

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hosogi, H., Shinohara, H., Tsunoda, S. et al. Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors. Langenbecks Arch Surg 402, 33–39 (2017). https://doi.org/10.1007/s00423-016-1536-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-016-1536-7

Keywords

Navigation